Literature DB >> 9204733

Surgical indications for treatment of pulmonary tuberculosis.

J Freixinet1.   

Abstract

Surgery for pulmonary tuberculosis (PTB) has passed through various stages throughout history, having been the treatment of choice in the past. It has now been relegated to second place for treatment of this disease. One of the most strongly debated surgical indications has been clinical picture of multidrug resistance with the focus of pulmonary tuberculous activity located in a segment, lobe, or lung. In these cases some authors have described good results with surgical excision. Another important indication is the complications of PTB, among which bronchiectases (provoking pictures of suppuration, superinfections, or hemoptysis) are found, along with known destructive pulmonary sequelae such as destroyed lung, massive hemoptysis, and the presence of a bronchopleural fistula that cannot be resolved with pleural drainage. The presence of a neoplasm in a patient affected by PTB is a surgical indication if the lesion is resectable. The existence of an unidentifiable pulmonary mass or node is a surgical criterion because it might signal bronchogenic carcinoma. A frequent indication for surgery is pulmonary aspergilloma, which in a large percentage of cases is a destructive PTB sequela and generates serious complications, hemoptysis being the most frequent. Mediastinal tuberculous lymphadenitis that produces compressive symptoms and pulmonary complications, especially in children, is another surgical indication for decompressing the bronchial tree. The surgery in these cases consists in excision and curettage of adenopathies. Surgery therefore now constitutes a valid option for the treatment of certain clinical pictures of PTB that do not respond to medical treatment, are serious, and are potentially fatal.

Entities:  

Mesh:

Year:  1997        PMID: 9204733     DOI: 10.1007/pl00012272

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  5 in total

1.  Surgical management of multidrug-resistant tuberculosis.

Authors:  S Sasano; H Yamamoto; T Otsuka; A Fujita; T Onuki; S Nitta
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-02

2.  Resection of a pulmonary lesion after liver transplantation: report of a case.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Jun Nakajima; Yoji Kishi; Takashi Niiya; Junichi Kaneko; Masatoshi Makuuchi
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Mortality hazard and survival after tuberculosis treatment.

Authors:  Thaddeus L Miller; Fernando A Wilson; Jenny W Pang; Suzanne Beavers; Sally Hoger; Sharon Sharnprapai; Melissa Pagaoa; Dolly J Katz; Stephen E Weis
Journal:  Am J Public Health       Date:  2015-03-19       Impact factor: 9.308

Review 4.  Efficiency and safety of surgical intervention to patients with Non-Cystic Fibrosis bronchiectasis: a meta-analysis.

Authors:  Li-Chao Fan; Shuo Liang; Hai-Wen Lu; Ke Fei; Jin-Fu Xu
Journal:  Sci Rep       Date:  2015-12-02       Impact factor: 4.379

5.  Association of Mortality and Years of Potential Life Lost With Active Tuberculosis in the United States.

Authors:  Christian Lee-Rodriguez; Paul Y Wada; Yun-Yi Hung; Jacek Skarbinski
Journal:  JAMA Netw Open       Date:  2020-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.